INT292080

Context Info Confidence 0.04 First Reported 2010 Last Reported 2010 Negated 0 Speculated 0 Reported most in Body Documents 1 Total Number 1 Disease Relevance 1.47 Pain Relevance 0.04

cytoplasm (FLT1, TXK) nucleus (FLT1, TXK) plasma membrane (FLT1, TXK) cell differentiation (FLT1) endosome (FLT1) Golgi apparatus (FLT1)

FLT1 (Homo sapiens) TXK (Homo sapiens)

Pain Link Frequency Relevance Heat nud 1 81.40 imagery 6 5.00 Pain 3 5.00 positron emission tomography 3 5.00 metalloproteinase 2 5.00 cva 2 5.00 antagonist 2 5.00 cytokine 1 5.00 Central nervous system 1 5.00 abdominal pain 1 5.00

Disease Link Frequency Relevance Heat Thyroid Disease 2 93.60 Hyperplasia 1 92.40 Thrombocytopenia 1 90.08 Neutropenia 1 88.24 Appetite Loss 1 87.08 Stomatitis 1 86.04 Vomiting 4 85.00 Syndrome 1 84.04 Hypertension 4 82.60 Dyspepsia 1 81.40

Sentences Mentioned In

Key:

Protein

Mutation

Event

Anatomy

Negation

Speculation

Pain term

Disease term

The molecule also inhibits other tyrosine kinase receptors including VEGFR1, VEGFR2, VEGFR3, PDGFRB, flt-3, and c-kit.

VEGFR1 Binding (receptors) of tyrosine kinase

1) Confidence 0.04 Published 2010 Journal Journal of Oncology Section Body Doc Link PMC2804796 Disease Relevance 1.47 Pain Relevance 0.04

General Comments

This test has worked.